Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Eva Simona Hägler-Laube"'
Autor:
Riccardo Asteggiano, Bonnie Ky, Alain Cohen-Solal, Dan Lenihan, Carlo G. Tocchetti, Markus S. Anker, Stephan von Haehling, Hadi Skouri, Javid Moslehi, Frank Ruschitzka, Peter A. Henriksen, Thomas M. Suter, Jean-Sébastien Hulot, Susan Dent, Teresa López Fernández, Jereon Bax, Mitja Lainscak, Alexander R. Lyon, Eva Simona Hägler-Laube, Radek Pudil, Fortunato Ciardiello, Daniela Cardinale, Dimitrios Farmakis, Ana Barac, Zaza Iakobishvili, Martin Štěrba, Susanna Stanway, Andrew J.S. Coats, Rudolf A. de Boer, Christian Mueller, Petar M. Seferovic, Ovidiu Chioncel, Christoph Maack, Massimo F Piepoli, Jutta Bergler-Klein, Y N Belenkov, Jelena Čelutkienė
Publikováno v:
European Journal of Heart Failure. 22:1966-1983
Serum biomarkers are an important tool in the baseline risk assessment and diagnosis of cardiovascular disease in cancer patients receiving cardiotoxic cancer treatments. Increases in cardiac biomarkers including cardiac troponin and natriuretic pept
Autor:
Radek, Pudil, Christian, Mueller, Jelena, Čelutkienė, Peter A, Henriksen, Dan, Lenihan, Susan, Dent, Ana, Barac, Susanna, Stanway, Javid, Moslehi, Thomas M, Suter, Bonnie, Ky, Martin, Štěrba, Daniela, Cardinale, Alain, Cohen-Solal, Carlo Gabriele, Tocchetti, Dimitrios, Farmakis, Jutta, Bergler-Klein, Markus S, Anker, Stephan, Von Haehling, Yury, Belenkov, Zaza, Iakobishvili, Christoph, Maack, Fortunato, Ciardiello, Frank, Ruschitzka, Andrew J S, Coats, Petar, Seferovic, Mitja, Lainscak, Massimo F, Piepoli, Ovidiu, Chioncel, Jereon, Bax, Jean-Sebastien, Hulot, Hadi, Skouri, Eva Simona, Hägler-Laube, Riccardo, Asteggiano, Teresa Lopez, Fernandez, Rudolf A, de Boer, Alexander R, Lyon
Publikováno v:
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (11), pp.1966-1983. ⟨10.1002/ejhf.2017⟩
European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (11), pp.1966-1983. ⟨10.1002/ejhf.2017⟩
International audience; Serum biomarkers are an important tool in the baseline risk assessment and diagnosis of cardiovascular disease in cancer patients receiving cardiotoxic cancer treatments. Increases in cardiac biomarkers including cardiac tropo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1e5b2632fc9eb0fc7e0379666a1079fb
http://hdl.handle.net/11591/436399
http://hdl.handle.net/11591/436399